Crossmark

A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naïve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms

Crossref DOI link: https://doi.org/10.1038/s41386-023-01760-8

Published Online: 2023-10-30

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Dong-Mei

Chen, Da-Chun

Xiu, Mei-Hong

Wang, Li http://orcid.org/0000-0002-1459-3412
Kosten, Thomas R. http://orcid.org/0000-0003-1505-555X
Zhang, Xiang-Yang http://orcid.org/0000-0003-3326-382X
Funding

Funding for this research was provided by:

Funding for this study was provided by grants from CAS International Cooperation Research Program
License Information

Text and Data Mining valid from 2023-10-30

Version of Record valid from 2023-10-30
More Information

Article History

Received: 4 July 2023

Revised: 26 September 2023

Accepted: 16 October 2023

First Online: 30 October 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below